What did @thisisjustme77 actually say?
After ten days on tirzepatide at the 2.5 mg starting dose, this creator says they finally felt appetite suppression for the first time. They described feeling "like this is now working" after a day where they ate a smoothie, scrambled eggs, and not much else. They also mentioned constipation that resolved after adding fiber, and they're considering whether to move to the 5 mg dose. Their stated goal is fitting comfortably in jeans, not watching the scale obsessively. That is, genuinely, a more reasonable framing than most GLP-1 content you'll see on this platform.
Does the science back this up?
On the core timeline claim, yes, mostly. The 2.5 mg starting dose of tirzepatide is a titration dose, not a therapeutic dose. It exists to let your gut adjust, not to drive meaningful appetite suppression. Frías et al. (2021, New England Journal of Medicine), the SURPASS-2 trial, showed that meaningful weight loss and appetite effects scaled with dose, with 5 mg and above producing significantly greater outcomes than the initiation dose. Feeling little at 2.5 mg in week one is expected, not a product failure.
The fiber fix for constipation is also well-supported. GLP-1 and GIP receptor agonists slow gastric motility, and constipation is one of the most commonly reported gastrointestinal side effects, affecting roughly 11 percent of tirzepatide users in the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM). Dietary fiber is a standard first-line response before considering laxatives or dose adjustments.
What did they get wrong (or right)?
There is nothing factually wrong in this video, which is somewhat unusual for GLP-1 content on TikTok. The creator did not overclaim. They did not say tirzepatide "melts fat" or "resets your metabolism." They described their subjective experience accurately and with appropriate uncertainty.
One thing worth flagging: the creator mentions getting a message asking whether to "go up now" to 5 mg after just ten days. Standard prescribing guidance, as outlined in the Mounjaro US label, is to stay at each dose for at least four weeks before titrating. Moving up after ten days because suppression just kicked in would be premature and could increase GI side effect risk. That decision should go through their prescriber, not a message prompt from an app.
The food choices described, a spinach and berry smoothie with oat milk, scrambled eggs, plenty of water, are genuinely solid. No complaints there.
What should you actually know?
The 2.5 mg starting dose of tirzepatide is designed for tolerability, not effect. If you felt nothing in week one, that is not a malfunction. The therapeutic action builds with dose and time. Wróbel et al. (2023, Diabetes, Obesity and Metabolism) noted that appetite-regulating effects of dual GIP/GLP-1 agonists like tirzepatide are dose-dependent and receptor-saturation-dependent, meaning the starting dose occupies relatively few receptors compared to higher maintenance doses.
On the dose escalation question: do not let an app or a notification decide when you go up. Four weeks at each dose is the standard titration interval. Going faster increases the likelihood of nausea, vomiting, and gastroparesis symptoms without meaningfully accelerating weight loss outcomes. Your prescriber should be making that call based on your tolerability, not a prompt.
And the jeans goal? Honestly, that is a reasonable functional health target. Research consistently shows that patient-centered, non-scale outcomes improve medication adherence and long-term success (Tronieri et al., 2023, Obesity Reviews). Fixating only on the number can lead to frustration during normal weight fluctuation plateaus.